Several domains from VAR2CSA can induce Plasmodium falciparum adhesion-blocking antibodies
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Malaria caused by Plasmodium falciparum can result in several different syndromes with severe clinical consequences for the about 200 million individuals infected each year. During pregnancy, women living in endemic areas become susceptible to malaria due to lack of antibodies against a unique P. falciparum membrane protein, named VAR2CSA. This antigen is not expressed in childhood infections, since it binds chondroitin sulphate A (CSA) expressed on the intervillous space in the placenta. A vaccine appears possible because women acquire protective antibodies hindering sequestration in the placenta as a function of parity. A challenge for vaccine development is to design small constructs of this large antigen, which can induce broadly protective antibodies. It has previously been shown that one domain of VAR2CSA, DBL4-FCR3, induces parasite adhesion-blocking antibodies. In this study, it is demonstrated that other domains of VAR2CSA also can induce antibodies with inhibitory activity. METHODS: All VAR2CSA domains from the 3D7 and HB3 parasites were produced in Baculovirus-transfected insect cells. Groups of three rats per protein were immunized and anti-sera were tested for surface reactivity against infected erythrocytes expressing FCR3 VAR2CSA and for the ability to inhibit FCR3CSA parasite adhesion to CSA. The fine specificity of the immune sera was analysed by VAR2CSA peptide arrays. RESULTS: Inhibitory antibodies were induced by immunization with DBL3-HB3 T1 and DBL1-3D7. However, unlike the previously characterised DBL4-FCR3 response the inhibitory response against DBL1-3D7 and DBL3-HB3 T1 was poorly reproduced in the second rounds of immunizations. CONCLUSION: It is possible to induce parasite adhesion-blocking antibodies when immunizing with a number of different VAR2CSA domains. This indicates that the CSA binding site in VAR2CSA is comprised of epitopes from different domains.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Antibodies raised to all DBL domains of 3D7 allele type reduced the adhesion of heterologous FCR3 IE by 50–65% compared to control, with the exception of antibodies to DBL1 that almost completely inhibited FCR3 binding to CSA [49].”
From Designing a VAR2CSA-based vaccine to prevent placental malaria (2015) · cites this paper as [49]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Of the DBL domains of HB3 allele, only DBL3 induced anti-adhesion antibodies that almost completely inhibited the binding of FCR3 IE to CSA [49].”
From Designing a VAR2CSA-based vaccine to prevent placental malaria (2015) · cites this paper as [49]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Su, X.-Z., Heatwole, V. M., Wertheimer, S. P., Guinet, F., Herrfeldt, J. A., Peterson, D. S., Ravetch, J. A., & Wellems, T. E. (1995) · Cell · doi:10.1016/0092-8674(95)90055-1 · Cited by 1,219
Baruch, D. I., Pasloske, B. L., Singh, H. B., Bi, X., Ma, X. C., Feldman, M., Taraschi, T. F., & Howard, R. J. (1995) · Cell · doi:10.1016/0092-8674(95)90054-3 · Cited by 1,030 · cited 1×
“and a high sequence variation among genomes [4-6].”
Smith, J. D., Chitnis, C. E., Craig, A. G., Roberts, D. J., Hudson-Taylor, D. E., Peterson, D. S., Pinches, R., Newbold, C. I., & Miller, L. H. (1995) · Cell · doi:10.1016/0092-8674(95)90056-x · Cited by 1,005 · cited 1×
“and a high sequence variation among genomes [4-6].”
An analysis of malaria in pregnancy in Africa.
Brabin, B. J. (1983) · PubMed · Cited by 782
Salanti, A., Staalsoe, T., Lavstsen, T., Jensen, A. T. R., Sowa, M. P. K., Arnot, D. E., Hviid, L., & Theander, T. G. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03570.x · Cited by 702 · cited 1×
“Placental parasites and parasite lines selected for CSA binding in vitro express a unique var gene named var2csa [10,11].”
Self-citationMaternal antibodies block malaria
Fried, M., Nosten, F., Brockman, A., Brabin, B. J., & Duffy, P. E. (1998) · Nature · doi:10.1038/27570 · Cited by 659 · cited 1×
“The mechanism of protection is suggested to be based on antibodies that block binding of IE to CSA [19].”
Bull, P. C., Lowe, B. S., Kortok, M., Molyneux, C. S., Newbold, C. I., & Marsh, K. (1998) · Nature Medicine · doi:10.1038/nm0398-358 · Cited by 645 · cited 1×
“Expression of different PfEMP1 variants allow the parasites to escape previously acquired antibody responses, and clinical protection occurs when a large repertoire of variant specific antibodies allows the host to control the infection [7].”
Evidence for the Involvement of VAR2CSA in Pregnancy-associated Malaria
Salanti, A., Dahlbäck, M., Turner, L., Nielsen, M. A., Barfod, L., Magistrado, P., Jensen, A. T. R., Lavstsen, T., Ofori, M. F., Marsh, K., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20041579 · Cited by 604 · cited 11×
“Likewise, high anti-VAR2CSA IgG levels are correlated with protection against the clinical consequences of PAM [13].”
InfluentialSelf-citationJensen, A. T. R., Magistrado, P., Sharp, S., Joergensen, L., Lavstsen, T., Chiucchiuini, A., Salanti, A., Vestergaard, L. S., Lusingu, J. P., Hermsen, R., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040274 · Cited by 322 · cited 1×
“After repeated infections during childhood in endemic areas the acquired repertoire of antibodies against the variant surface antigens will progressively protect against variants expressed during severe, mild and asymptomatic infections [8,9].”
Self-citationFried, M., Muga, R., Misore, A. O., & Duffy, P. E. (1998) · PubMed · Cited by 321
Cited by
Designing a VAR2CSA-based vaccine to prevent placental malaria
Fried, M., & Duffy, P. E. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.10.011 · Cited by 86
“Antibodies raised to all DBL domains of 3D7 allele type reduced the adhesion of heterologous FCR3 IE by 50–65% compared to control, with the exception of antibodies to DBL1 that almost completely inhibited FCR3 binding to CSA [49].”
BackgroundThe Chondroitin Sulfate A-binding Site of the VAR2CSA Protein Involves Multiple N-terminal Domains
Dahlbäck, M., Jørgensen, L. M., Nielsen, M. A., Clausen, T. M., Ditlev, S. B., Resende, M., Pinto, V. V., Arnot, D. E., Theander, T. G., & Salanti, A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.191510 · Cited by 85
Self-citationVar2CSA minimal CSA binding region is located within the N-terminal region
Srivastava, A., Gangnard, S., Dechavanne, S., Amirat, F., Lewit Bentley, A., Bentley, G. A., & Gamain, B. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020270 · Cited by 76
“However, adhesion inhibitory activities are not consistent between various DBL4e and DBL5e antigen preparations [31,44].”
BackgroundGhumra, A., Khunrae, P., Ataíde, R., Raza, A., Rogerson, S. J., Higgins, M. K., & Rowe, J. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016414 · Cited by 60
Houngbedji, C. A., N’Dri, P. B., Hürlimann, E., Yapi, R. B., Silué, K. D., Soro, G., Koudou, B. G., Acka, C. A., Assi, S.-B., Vounatsou, P., et al. (2015) · Malaria Journal · doi:10.1186/1475-2875-14-7 · Cited by 67
Metadata
- Authors
- Salanti, A., Resende, M., Ditlev, S. B., Pinto, V. V., Dahlbäck, M., Andersen, G., Manczak, T., Theander, T. G., & Nielsen, M. A.
- Affiliations
- University of Copenhagen (DK)
- Corresponding author
- Salanti, Ali
- Venue
- Malaria Journal
- Published
- 2010-01-11
- Volume
- 9
- Issue
- 1
- Pages
- 11-11
- ISSN
- 1475-2875 (ISSN-L)
- PMC
- PMC2817698
- OpenAlex
- W2159968240
- Cited by
- 42
- References
- 30
- Citations by year
- 2023: 2 · 2021: 3 · 2020: 2 · 2018: 1 · 2017: 3 · 2016: 2 · 2015: 7 · 2013: 2 · 2012: 4
- FWCI
- 6.97
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/2.0 (tdm)
- Locations
- Malaria Journal (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Funders
- Bill and Melinda Gates Foundation
- European Commission (201222)
- Danmarks Frie Forskningsfond
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
- Health Sciences › Medicine › Hematology › Blood groups and transfusion
- Life Sciences › Immunology and Microbiology › Parasitology › Vector-borne infectious diseases
- Keywords
- VAR2CSA, Plasmodium falciparum, placental malaria, chondroitin sulfate A, DBL domains, placental sequestration, malaria vaccine, epitope mapping
- MeSH terms
- Animals, Antibodies, Protozoan, Antigens, Protozoan, Cell Adhesion, Female, Genetic Vectors, Humans, Insecta, Pregnancy, Vaccines, Synthetic, Baculoviridae, Rats, Wistar, Protein Structure, Tertiary, Malaria Vaccines, Vaccines, Subunit, Rats, Antibodies, Neutralizing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Several domains from VAR2CSA can induce Plasmodium falciparum adhesion-blocking antibodies. https://app.cochat.ai/papers/10.1186/1475-2875-9-11
- The paper
- Salanti, A., Resende, M., Ditlev, S. B., Pinto, V. V., Dahlbäck, M., Andersen, G., Manczak, T., Theander, T. G., & Nielsen, M. A. (2010). Several domains from VAR2CSA can induce Plasmodium falciparum adhesion-blocking antibodies. Malaria Journal. https://doi.org/10.1186/1475-2875-9-11
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.